|
Receptor pharmacology
Citations 61-70 of 142 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Methoxyestradiols Mediate the Antimitogenic Effects of 17 -Estradiol. Direct Evidence From Catechol-O-Methyltransferase-Knockout Mice
- Lefteris C. Zacharia, Joseph A. Gogos, Maria Karayiorgou, Edwin K. Jackson, Delbert G. Gillespie, Federica Barchiesi, and Raghvendra K. Dubey
Circulation published December 8, 2003, doi:10.1161/01.CIR.0000106900.66354.30
[Abstract]
- Basic Science Reports
Dual Inhibition of ß-Adrenergic and Angiotensin II Receptors by a Single Antagonist: A Functional Role for ReceptorReceptor Interaction In Vivo
- Liza Barki-Harrington, Louis M. Luttrell, and Howard A. Rockman
Circulation 2003;108:1611-1618; published online before print as doi:10.1161/01.CIR.0000092166.30360.78
[Abstract]
[Full text]
- Basic Science Reports
Dual Inhibition of ß-Adrenergic and Angiotensin II Receptors by a Single Antagonist: A Functional Role for ReceptorReceptor Interaction In Vivo
- Liza Barki-Harrington, Louis M. Luttrell, and Howard A. Rockman
Circulation published September 8, 2003, doi:10.1161/01.CIR.0000092166.30360.78
[Abstract]
[Full text]
- Correspondence
Caffeine and Coffee Tolerance Response
- Shepard Siegel, Marta Sokolowska, Joseph A. Kim, William R. Lovallo, Thomas L. Whitsett, Michael F. Wilson, Jan Schmitt, Johanna Schmitt, Catherine F. Notarius, Gerard A. Rongen, John S. Floras, Roberto Corti, Christian Binggeli, Isabella Sudano, Lukas Spieker, Frank Ruschitzka, Thomas F. Lüscher, Georg Noll, Edgar Hänseler, and William F. Chaplin
Circulation 2003;108:e38-40e, doi:10.1161/01.CIR.0000084389.38167.7E
[Full text]
- Basic Science Reports
Partial Agonist Activity of Bucindolol Is Dependent on the Activation State of the Human ß1-Adrenergic Receptor
- Christoph Maack, Michael Böhm, Lydia Vlaskin, Ewtim Dabew, Kristina Lorenz, Hans-Joachim Schäfers, Martin J. Lohse, and Stefan Engelhardt
Circulation 2003;108:348-353; published online before print as doi:10.1161/01.CIR.0000080325.94345.8B
[Abstract]
[Full text]
- Articles
349Partial Agonist Activity of Bucindolol Is Dependent on the Activation State of the Human 1-Adrenergic Receptor
- Christoph Maack, Michael Böhm, Lydia Vlaskin, Ewtim Dabew, Kristina Lorenz, Hans-Joachim Schäfers, Martin J. Lohse, and Stefan Engelhardt
Circulation published July 7, 2003, doi:10.1161/01.CIR.0000080325.94345.8B
[Abstract]
- Correspondence
Endothelin Receptor Blockade and Exacerbation of Heart Failure
- István Szokodi, Jarkko Piuhola, and Heikki Ruskoaho
Circulation 2003;107:e211, doi:10.1161/01.CIR.0000075859.90953.5A
[Full text]
- Basic Science Reports
Third-Generation ß-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux: A Novel Mechanism for Antihypertensive Action
- Leszek Kalinowski, Lawrence W. Dobrucki, Miroslawa Szczepanska-Konkel, Maciej Jankowski, Ludmila Martyniec, Stefan Angielski, and Tadeusz Malinski
Circulation 2003;107:2747-2752; published online before print as doi:10.1161/01.CIR.0000066912.58385.DE
[Abstract]
[Full text]
- Articles
Third-Generation -Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux. A Novel Mechanism for Antihypertensive Action
- Leszek Kalinowski, Lawrence W. Dobrucki, Miroslawa Szczepanska-Konkel, Maciej Jankowski, Ludmila Martyniec, Stefan Angielski, and Tadeusz Malinski
Circulation published May 12, 2003, doi:10.1161/01.CIR.0000066912.58385.DE
[Abstract]
- Clinical Investigations and Reports
Protease-Activated Receptor 2Mediated Vasodilatation in Humans In Vivo: Role of Nitric Oxide and Prostanoids
- Jonathan Robin, Rajesh Kharbanda, Peter Mclean, Richard Campbell, and Patrick Vallance
Circulation 2003;107:954-959; published online before print as doi:10.1161/01.CIR.0000050620.37260.75
[Abstract]
[Full text]
|
|